Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Leonardo DRS (DRS) Current Deferred Revenue (2020 - 2025)

Leonardo DRS's Current Deferred Revenue history spans 6 years, with the latest figure at $585.0 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 46.62% year-over-year to $585.0 million; the TTM value through Dec 2025 reached $585.0 million, up 46.62%, while the annual FY2025 figure was $585.0 million, 46.62% up from the prior year.
  • Current Deferred Revenue reached $585.0 million in Q4 2025 per DRS's latest filing, up from $440.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $585.0 million in Q4 2025 to a low of $147.0 million in Q2 2021.
  • Average Current Deferred Revenue over 5 years is $293.4 million, with a median of $275.0 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: dropped 1.69% in 2021, then soared 87.18% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $174.0 million in 2021, then skyrocketed by 33.91% to $233.0 million in 2022, then skyrocketed by 43.78% to $335.0 million in 2023, then rose by 19.1% to $399.0 million in 2024, then surged by 46.62% to $585.0 million in 2025.
  • Per Business Quant, the three most recent readings for DRS's Current Deferred Revenue are $585.0 million (Q4 2025), $440.0 million (Q3 2025), and $436.0 million (Q2 2025).